604P Predictive genomic biomarkers in non-metastatic castration resistant prostate cancer (nmCRPC) treated with androgen receptor pathway inhibitors (ARPi) von Gagnon, R., El Hallani, S.E., Lee-Ying, R., Kolinsky, M.P., Khalaf, D.J., Cook, S., Vasquez, C., Samuel, D., Lewis, J.D., Faridi, R.M., Borkar, M., Heng, D.Y.C., Alimohamed, N., Ruether, J.D., Gotto, G.T., Fairey, A., Bismar, T.A., Yip, S.

Volltext